Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Lenmid 10mg Tablets | 100-Count | LENALIDOMIDE
Pharma

Lenmid 10mg Tablets | 100-Count | LENALIDOMIDE

$200

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse LENALIDOMIDE — 10mg per tablet, 100-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile. Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.

SKU
VES-005612-LENMID-10MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Lenmid 10mg (LENALIDOMIDE)?

IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.

How it Works

Binds CRBN E3 ubiquitin ligase, promoting degradation of Ikaros and Aiolos — depletes myeloma survival signals and enhances T and NK cell immune responses.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
LENALIDOMIDE
Dose per Tablet
10MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Myelosuppression (neutropenia, thrombocytopenia), DVT/PE (mandatory prophylaxis), fatigue, diarrhea, rash, peripheral neuropathy.

Safety Warnings

TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.